CA2369910A1 - Compositions and methods for treatment of hyperproliferative diseases - Google Patents
Compositions and methods for treatment of hyperproliferative diseases Download PDFInfo
- Publication number
- CA2369910A1 CA2369910A1 CA002369910A CA2369910A CA2369910A1 CA 2369910 A1 CA2369910 A1 CA 2369910A1 CA 002369910 A CA002369910 A CA 002369910A CA 2369910 A CA2369910 A CA 2369910A CA 2369910 A1 CA2369910 A1 CA 2369910A1
- Authority
- CA
- Canada
- Prior art keywords
- agonist
- rxr
- rar
- compound
- camp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/008908 WO2000064260A1 (en) | 1999-04-23 | 1999-04-23 | Compositions and methods for treatment of hyperproliferative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2369910A1 true CA2369910A1 (en) | 2000-11-02 |
Family
ID=22272621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002369910A Abandoned CA2369910A1 (en) | 1999-04-23 | 1999-04-23 | Compositions and methods for treatment of hyperproliferative diseases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1173061A1 (de) |
JP (1) | JP2002542268A (de) |
AU (1) | AU773928B2 (de) |
CA (1) | CA2369910A1 (de) |
WO (1) | WO2000064260A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4866201A (en) * | 2000-04-13 | 2001-10-30 | Pierre Chambon | Compositions and methods for use in modulating immune system function |
WO2002045718A1 (en) * | 2000-12-08 | 2002-06-13 | Institut Pasteur De Lille | Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells |
JP5249484B2 (ja) * | 2001-12-11 | 2013-07-31 | 第一三共株式会社 | 医薬組成物 |
CA2495666C (en) * | 2002-08-14 | 2014-05-27 | Michael S. H. Chu | Systems, methods and devices relating to delivery of medical implants |
AU2003270202A1 (en) * | 2002-09-17 | 2004-04-08 | Centre National De La Recherche Scientifique | Pharmaceutical compositions increasing camp useful for the treatment of cancers |
GB0224415D0 (en) * | 2002-10-21 | 2002-11-27 | Medical Res Council | Compositions |
AU2003289467A1 (en) * | 2002-12-20 | 2004-07-14 | Eisai Co., Ltd. | Pka activity regulator |
US10328040B2 (en) | 2014-01-17 | 2019-06-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic methods |
US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5399586A (en) * | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
CA2334545A1 (en) * | 1998-06-12 | 1999-12-16 | Ligand Pharmaceuticals Incorporated | Treatment of anti-estrogen resistant breast cancer using rxr modulators |
-
1999
- 1999-04-23 WO PCT/US1999/008908 patent/WO2000064260A1/en not_active Application Discontinuation
- 1999-04-23 EP EP99925558A patent/EP1173061A1/de not_active Withdrawn
- 1999-04-23 JP JP2000613263A patent/JP2002542268A/ja active Pending
- 1999-04-23 AU AU41815/99A patent/AU773928B2/en not_active Ceased
- 1999-04-23 CA CA002369910A patent/CA2369910A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4181599A (en) | 2000-11-10 |
AU773928B2 (en) | 2004-06-10 |
EP1173061A1 (de) | 2002-01-23 |
WO2000064260A1 (en) | 2000-11-02 |
JP2002542268A (ja) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6653322B1 (en) | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | |
WO1998008546A9 (en) | Therapeutic combinations of rar antagonists and rxr agonists and use thereof | |
Chomienne et al. | Retinoid differentiation therapy in promyelocytic leukemia | |
AU773928B2 (en) | Compositions and methods for treatment of hyperproliferative diseases | |
KR100353654B1 (ko) | 레티노이드엑스수용체호모이합체형성을위한브릿지된바이사이클릭방향족화합물 | |
AU1345097A (en) | Methods of treatment with compounds having raralpha receptor specific or selective activity | |
US6184256B1 (en) | Methods and compositions for use in modulating expression of matrix metalloproteinase genes | |
US6624154B1 (en) | Compositions and methods for treatment of hyperproliferative diseases | |
Leal et al. | Potential therapeutic uses of rexinoids | |
AU701790B2 (en) | Method for treating cancers using 6-{3-{1-adamantyl}- 4-hydroxyphenyl} | |
JP4435418B2 (ja) | 新規レチノイドおよびその使用法 | |
US6713515B2 (en) | Retinoic acid receptor antagonists as promoters of angiogenesis | |
US20020090352A1 (en) | Compositions and methods for use in modulating immune system function | |
Crowe | Receptor selective synthetic retinoids as potential cancer chemotherapy agents | |
US20040122080A1 (en) | Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
JP2004528316A (ja) | 癌治療のための、レチノイド受容体リガンドおよび選択される細胞毒性剤の相乗的な組み合わせ | |
MXPA99001757A (en) | Therapeutic combinations of rar antagonists and rxr agonists and use thereof | |
AU2002305072A1 (en) | Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
CHOMIENNE et al. | P LEFEBVRE, N BALITRAND, S BARBEY, H DE THE, P FENAUX, L DEGOS | |
US20020048580A1 (en) | Method of inducing lung branching | |
Chomienne | Molecular Basis for Retinoic Acid Effects in Acute Promyelocytic Leukemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |